---
title: "BIOSINO BIO-TEC: Chen Zhengyong appointed as authorized representative"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/248566551.md"
description: "BIOSINO BIO-TEC announced that Mr. Wu Lebin was removed from his position as a director at the special shareholders' meeting, and Mr. Chen Zhengyong was appointed as the authorized representative and chairman of the nomination committee. Mr. Lu Qi resigned as an independent non-executive director, and Mr. Fan Xiaoliang was appointed as an independent non-executive director and chairman of the audit committee, with the appointments effective from July 15, 2025"
datetime: "2025-07-15T09:01:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248566551.md)
  - [en](https://longbridge.com/en/news/248566551.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248566551.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/248566551.md) | [繁體中文](https://longbridge.com/zh-HK/news/248566551.md)


# BIOSINO BIO-TEC: Chen Zhengyong appointed as authorized representative

According to the announcement from BIOSINO BIO-TEC (08247), following the approval of Mr. Wu Lebin's removal by shareholders at the special general meeting, he will no longer serve as a director at the end of the meeting.

Following Mr. Wu's removal from the board, the board further announced that, effective July 15, 2025, (i) Mr. Wu will also no longer serve as a member of the nomination committee and authorized representative; and (ii) Executive Director and Chairman of the Board, Mr. Chen Zhengyong, has been appointed as the authorized representative.

After the shareholders approved the appointment of Mr. Fan Xiaoliang as an independent non-executive director at the special general meeting, Mr. Lu Qi's resignation as an independent non-executive director became effective at the end of the meeting.

Following Mr. Lu's resignation as an independent non-executive director, the board further announced that, effective July 15, 2025, (i) Mr. Lu will also no longer serve as the chairman of the audit committee and nomination committee, as well as a member of the remuneration committee; and (ii) Executive Director and Chairman of the Board, Mr. Chen Zhengyong, has been appointed as the chairman of the nomination committee.

After the shareholders approved the appointments of Dr. Shen Sheng and Mr. Fan Xiaoliang at the special general meeting, they have been appointed as non-executive director and independent non-executive director, respectively, effective July 15, 2025.

Following Mr. Fan's appointment as an independent non-executive director, the board further announced that, effective July 15, 2025, he has also been appointed as the chairman of the audit committee

### 相关股票

- [BIOSINO BIO-TEC (08247.HK)](https://longbridge.com/zh-CN/quote/08247.HK.md)

## 相关资讯与研究

- [Guan Chao's Loss Balloons in 2025](https://longbridge.com/zh-CN/news/281314987.md)
- [Zhongtai Securities Sticks to Its Buy Rating for Wasion Holdings Limited (3393)](https://longbridge.com/zh-CN/news/281141455.md)
- [Guotai Haitong Remains a Buy on Jinxin Fertility Group Ltd. (1951)](https://longbridge.com/zh-CN/news/281098586.md)
- [North Western Railway to run special trains until July 15 amid summer rush](https://longbridge.com/zh-CN/news/281603955.md)
- [Guotai Haitong Sticks to Their Buy Rating for Zhongsheng Group Holdings Ltd. (0881)](https://longbridge.com/zh-CN/news/281307317.md)